E
Cresco Labs Inc. CL
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 12/20/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 12/20/2024 due to a decline in the total return index, volatility index and valuation index.
D
Sell 10/10/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 10/10/2024 due to an increase in the volatility index.
E
Sell 9/24/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 9/24/2024 due to a decline in the volatility index.
D
Sell 9/5/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 9/5/2024 due to an increase in the volatility index and valuation index.
E
Sell 8/16/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 8/16/2024 due to a decline in the volatility index.
D
Sell 8/8/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 8/8/2024 due to an increase in the volatility index.
E
Sell 7/19/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 7/19/2024 due to a decline in the volatility index and total return index.
D
Sell 7/3/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 7/3/2024 due to an increase in the volatility index and solvency index. The quick ratio increased from 0.77 to 0.83.
E
Sell 6/20/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 6/20/2024 due to a decline in the volatility index and total return index.
D
Sell 6/4/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 6/4/2024 due to an increase in the volatility index.
E
Sell 5/14/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 5/14/2024 due to a decline in the volatility index and growth index.
D
Sell 4/29/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 4/29/2024 due to an increase in the total return index and volatility index.
E
Sell 3/18/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 3/18/2024 due to a decline in the volatility index and valuation index.
D
Sell 3/8/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 3/8/2024 due to an increase in the volatility index.
E
Sell 2/16/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 2/16/2024 due to a decline in the volatility index.
D
Sell 2/1/2024Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 2/1/2024 due to an increase in the volatility index and total return index.
E
Sell 1/11/2024Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 1/11/2024 due to a decline in the volatility index and total return index.
D
Sell 12/26/2023Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 12/26/2023 due to an increase in the volatility index and valuation index.
E
Sell 12/6/2023Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 12/6/2023 due to a decline in the volatility index and valuation index.
D
Sell 11/17/2023Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 11/17/2023 due to an increase in the solvency index, volatility index and total return index. The quick ratio increased from 0.55 to 0.63.
E
Sell 10/30/2023Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D- on 10/30/2023 due to a decline in the volatility index and total return index.
D
Sell 10/13/2023Upgraded
Cresco Labs Inc. (CL) was upgraded to D- from E+ on 10/13/2023 due to an increase in the volatility index and valuation index.
E
Sell 3/14/2023Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell 2/9/2023Upgraded
Cresco Labs Inc. (CL) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell 2/8/2023Downgrade
Cresco Labs Inc. (CL) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index, solvency index and valuation index. Debt to equity increased from 0.53 to 0.55.
D
Sell 11/10/2022Upgraded
Cresco Labs Inc. (CL) was upgraded to D from D- on 11/10/2022 due to an increase in the volatility index and total return index.
D
Sell 10/24/2022Downgrade
Cresco Labs Inc. (CL) was downgraded to D- from D on 10/24/2022 due to a decline in the volatility index and valuation index.
D
Sell 10/6/2022Upgraded
Cresco Labs Inc. (CL) was upgraded to D from D- on 10/6/2022 due to an increase in the total return index and volatility index.
D
Sell 7/7/2022Downgrade
Cresco Labs Inc. (CL) was downgraded to D- from D on 7/7/2022 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.93 to 0.69, and debt to equity increased from 0.58 to 0.59.
D
Sell 5/5/2022Upgraded
Cresco Labs Inc. (CL) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell 4/20/2022Downgrade
Cresco Labs Inc. (CL) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index, solvency index and volatility index. The quick ratio declined from 1.44 to 0.93.
D
Sell 11/22/2021Upgraded
Cresco Labs Inc. (CL) was upgraded to D from D- on 11/22/2021 due to an increase in the total return index.
D
Sell 11/8/2021Downgrade
Cresco Labs Inc. (CL) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the solvency index and valuation index. The quick ratio declined from 1.05 to 0.88.
D
Sell 5/20/2020Upgraded
Cresco Labs Inc. (CL) was upgraded to D from D- on 5/20/2020 due to an increase in the volatility index and valuation index.
D
Sell 5/5/2020Downgrade
Cresco Labs Inc. (CL) was downgraded to D- from D on 5/5/2020 due to a substantial decline in the efficiency index, growth index and total return index. EBIT declined 616.96% from -$3.47M to -$24.86M, net income declined 302.13% from -$6.96M to -$27.99M, and earnings per share declined from -$0.0603 to -$0.2209.
D
Sell 10/10/2019Downgrade
Cresco Labs Inc. (CL) was downgraded to D from D+ on 10/10/2019 due to a decline in the solvency index, volatility index and total return index.
D
Sell 9/3/2019Upgraded
Cresco Labs Inc. (CL) was upgraded to D+ from D on 9/3/2019 due to a large increase in the growth index and solvency index. EBIT increased 161.18% from -$7.09M to $4.34M, earnings per share increased from -$0.055 to -$0.02, and total revenue increased 43.31% from $20.33M to $29.13M.
D
Sell 8/1/2019Upgraded
Cresco Labs Inc. (CL) was upgraded to D from E on 8/1/2019 due to a large increase in the solvency index, total return index and valuation index.
E
Sell 2/27/2019None
Cresco Labs Inc. (CL) was downgraded to E from U on 02/27/2019.
Weiss Ratings